Important information for losing weight, weight loss pills and safe diet pills.

Just under 90% of people don’t know about the risks involved of carrying additional fat around the waistline, reports safedietpills.co.uk

The study, conducted by GlaxoSmithKline, the makers of the first FDA pill approved over the counter pill Alli, interviewed 12,000 people across Europe.

The survey found that the vats majority had no idea that a thick waist was a sign of a buildup of a dangerous type of fat around the internal organs.

The study  said that this “viscersal fat” was strongly linked with type 2 diabetes and heart disease. The survey found that once people were aware of such risks, they would lose weight.

The author of the study, Dr Terry Maguire a senior Lecturer at Queen’s University Belfast, said that people were ignorant of the fact that visceral fat, which you cannot see or feel and which sits around organs, exists or that it poses a threat.

Scientists believe that this type of fat is related to the release of proteins and hormones that can result in inflammation that can damage arteries and enter the liver, effecting how the body breaks down sugars and fats.

Rather worryingly, just 25% of those questioned believed that being overweight was a threat to long term health.

“Most overweight people still see themselves as having a body image issue not a health problem and they need to understand the health benefits of weight loss as well as the cosmetic results,” Dr Maguire revealed.

When quizzed on losing weight, 65% of respondents said they would try and lose weight in the new year.

The report’s co-author, Professor David Haslam, chair of the UK National Obesity Forum, warned, however,  that steady sustainable weight loss is the best method for long term sustainable weight loss.

He warned that ‘crash diets’ were doomed to fail and that “they can actually do more harm than good”.

The survey was commisioned by the makers of Alli, the first FDA approved weight loss supplement sold over the counter.

This clinically proven diet pill has been shown to help you lose up to 50% more weight then regular dieting.

It works by preventing the absorption of fats into the body.

For more information click here and read the full review now.

If you are interested in a 100% natural and side effect free alternative, Proactol may well be your answer.

Similarly to Alli, it is a fat binder, but unlike Alli, it has no side effects as it is 100% natural and organic.

For more information click here

Just how desperate are you to lose weight - desperate enough to have electrodes implanted in your brain? That’s the latest approach to tackling obesity now being tested.

With experts warning of an obesity epidemic, drugs companies and medics have been working on newer and better ways to tackle weight gain.

Most recently, the focus has been on prescription medicines, with the development of slimming pills such as Alli, which work by reducing the amount of fat your body absorbs.

Beyond weight loss supplements there has also been a rise in the use of gastric surgery - literally re-plumbing people’s stomachs so they eat less.

But in the U.S., the latest approach to tackling obesity is even more drastic. Deep brain stimulation (DBS), as it is known, involves inserting electrodes into the brain to deliver tiny bursts of electricity to alter the patient’s behaviour.

The new approach is being tested in a U.S. Government-approved trial, which is running for three years.

During the procedure, patients first have holes drilled into their skull. The electrodes are then implanted - these are attached to wires, which are fed across the surface of the brain and under the skin to a small battery implanted under the collarbone.

So far, two patients have had the operation, and early indications are ‘promising’, with both eating less and losing weight.

The surgery was performed by Dr Donald Whiting, a neurosurgeon at West Virginia University Hospital. Dr Whiting admits it is a drastic procedure - ‘but obesity is a drastic problem’.

Other experts question how effective the treatment will be.

‘I think tinkering with the brain might prove too difficult,’ says Professor Tipu Aziz, a consultant neurosurgeon at the John Radcliffe Hospital in Oxford. ‘The technique was attempted on a patient in Canada and it failed. They found it helped his depression, but did not affect his desire to eat.’

Yet some British experts believe that medically, this approach makes sense. As Dr Ian Campbell, of the medical charity Weight Concern, says: ‘We know that hormones and the hypothalamus play a role in suppressing appetite and so it would be logical to use the brain as a way of treating obesity.